195 related articles for article (PubMed ID: 12114524)
21. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors.
López-Vera E; Aguilar MB; Schiavon E; Marinzi C; Ortiz E; Restano Cassulini R; Batista CV; Possani LD; Heimer de la Cotera EP; Peri F; Becerril B; Wanke E
FEBS J; 2007 Aug; 274(15):3972-85. PubMed ID: 17635581
[TBL] [Abstract][Full Text] [Related]
22. AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
Teichert RW; Rivier J; Dykert J; Cervini L; Gulyas J; Bulaj G; Ellison M; Olivera BM
Toxicon; 2004 Aug; 44(2):207-14. PubMed ID: 15246771
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analogues.
Millard EL; Nevin ST; Loughnan ML; Nicke A; Clark RJ; Alewood PF; Lewis RJ; Adams DJ; Craik DJ; Daly NL
J Biol Chem; 2009 Feb; 284(8):4944-51. PubMed ID: 19098004
[TBL] [Abstract][Full Text] [Related]
24. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
[TBL] [Abstract][Full Text] [Related]
25. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM
J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900
[TBL] [Abstract][Full Text] [Related]
26. A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
Cartier GE; Yoshikami D; Gray WR; Luo S; Olivera BM; McIntosh JM
J Biol Chem; 1996 Mar; 271(13):7522-8. PubMed ID: 8631783
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.
Sambasivarao SV; Roberts J; Bharadwaj VS; Slingsby JG; Rohleder C; Mallory C; Groome JR; McDougal OM; Maupin CM
Chembiochem; 2014 Feb; 15(3):413-24. PubMed ID: 24420650
[TBL] [Abstract][Full Text] [Related]
28. Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
Azam L; Dowell C; Watkins M; Stitzel JA; Olivera BM; McIntosh JM
J Biol Chem; 2005 Jan; 280(1):80-7. PubMed ID: 15520009
[TBL] [Abstract][Full Text] [Related]
29. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
30. Isolation, structure, and activity of GID, a novel alpha 4/7-conotoxin with an extended N-terminal sequence.
Nicke A; Loughnan ML; Millard EL; Alewood PF; Adams DJ; Daly NL; Craik DJ; Lewis RJ
J Biol Chem; 2003 Jan; 278(5):3137-44. PubMed ID: 12419800
[TBL] [Abstract][Full Text] [Related]
31. Structure-Function Elucidation of a New α-Conotoxin, MilIA, from
Peigneur S; Devi P; Seldeslachts A; Ravichandran S; Quinton L; Tytgat J
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527432
[TBL] [Abstract][Full Text] [Related]
32. Characterization of an α 4/7-Conotoxin LvIF from
Guo M; Yu J; Zhu X; Zhangsun D; Luo S
Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356823
[TBL] [Abstract][Full Text] [Related]
33. A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
Teichert RW; Rivier J; Torres J; Dykert J; Miller C; Olivera BM
J Neurosci; 2005 Jan; 25(3):732-6. PubMed ID: 15659611
[TBL] [Abstract][Full Text] [Related]
34. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
35. Determinants of potency on alpha-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors.
Everhart D; Cartier GE; Malhotra A; Gomes AV; McIntosh JM; Luetje CW
Biochemistry; 2004 Mar; 43(10):2732-7. PubMed ID: 15005608
[TBL] [Abstract][Full Text] [Related]
36. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
37. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
38. Conus peptides: novel probes for nicotinic acetylcholine receptor structure and function.
McIntosh JM; Gardner S; Luo S; Garrett JE; Yoshikami D
Eur J Pharmacol; 2000 Mar; 393(1-3):205-8. PubMed ID: 10771014
[TBL] [Abstract][Full Text] [Related]
39. A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily.
Luo S; Christensen S; Zhangsun D; Wu Y; Hu Y; Zhu X; Chhabra S; Norton RS; McIntosh JM
PLoS One; 2013; 8(1):e54648. PubMed ID: 23382933
[TBL] [Abstract][Full Text] [Related]
40. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
